Back to the Mental Health Monitor
Americans’ anxiety toward upcoming Presidential election has increased; mental health expert encourages treatment for those who are impacted
Phase II of GeneSight® Mental Health Monitor Election Survey from Myriad Genetics Shows 41% of Americans Report Feeling Anxious as the Election Draws Closer
Special Election Series Update
The GeneSight Mental Health Monitor is a nationwide survey conducted online by ACUPOLL Precision Research, Inc. Phase I was conducted between May 8-15, 2024, and Phase II was conducted between July 23-30, 2024, among a representative sample (n=1000) of U.S. adults age 18+. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%. A nationally representative sample of adults aged 18 years or older was recruited and balanced to match U.S. Census quotas across five primary metrics (i.e., age, gender, income, region, ethnicity).
In addition to the nationally representative sample, a statistically reliable sample was desired of respondents who were self-reported as being diagnosed by a medical professional with depression or anxiety. The study also used mental health screening instruments, the Patient Health Questionnaire-2 (PHQ-2) for depression, and the General Anxiety Disorder (GAD-2) for anxiety, to better understand this population.
ACUPOLL has more than 30 years of experience conducting statistically valid research through careful recruiting and quality control measures.